Answers are grounded in this paper and cite their sources.
New, effective, and well-tolerated oral therapies are needed for treating psoriasis. Zasocitinib, a highly selective allosteric tyrosine kinase 2 (TYK2) inhibitor, is a potential new oral treatment for this disease.
No takes yet. Share an insight, caveat, or question.
Armstrong et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: